Key result
The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionary signature of ZAP, as multiple dinucleotides show altered representations and ZAP optimal binding motifs are not specifically depleted.
Why the study?
To investigate the hypothesis that the low abundance of CpG in the SARS-CoV-2 genome is due to evolutionary pressure exerted by the host zinc finger antiviral protein (ZAP).
Supports ZAP-driven CpG depletion in coronaviruses; leaves open functional consequences for SARS-CoV-2 replication.
The zinc finger antiviral protein (ZAP) is known to restrict viral replication by binding to the CpG rich regions of viral RNA, and subsequently inducing viral RNA degradation. This enzyme has recently been shown to be capable of restricting SARS-CoV-2. These data have led to the hypothesis that the low abundance of CpG in the SARS-CoV-2 genome is due to an evolutionary pressure exerted by the host ZAP. To investigate this hypothesis, we performed a detailed analysis of many coronavirus sequences and ZAP RNA binding preference data. Our analyses showed neither evidence for an evolutionary pressure acting specifically on CpG dinucleotides, nor a link between the activity of ZAP and the low CpG abundance of the SARS-CoV-2 genome.
No takes yet. Share an insight, caveat, or question.
Afrasiabi et al. (2022) studied SARS-CoV-2 (n=6,220). ZAP evolutionary pressure vs. SARS-CoV and non-ZAP binding motifs was evaluated on Abundance of ZAP optimal binding motif C(n7)G(n)CG compared to control motif C(n7)C(n)CG in SARS-CoV-2-like viruses (p=>0.05). The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionary signature of ZAP, as multiple dinucleotides show altered representations and ZAP optimal binding motifs are not specifically depleted.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: